DiaSorin

You're invited to the ASM Workshop: Rapidly Ruling Out Bacterial Infection in the Emergency Departments of a Tertiary Cancer Center: The LIAISON® MeMed BV® Test. We are pleased to welcome Dr. David M. Engman, Chairman Emeritus of the Department of Pathology and Laboratory Medicine at Cedars-Sinai Medical Center, who will provide an overview of a novel diagnostic assay designed to distinguish bacterial from viral infections and identify co-infections. Also welcome Krupa Jani, an ASCP-certified Clinical Laboratory Technologist and current Research Technologist in Clinical Microbiology Services at Memorial Sloan Kettering Cancer Center. She will share insights on the performance of the LIAISON® MeMed BV® test in cancer patients. This session will offer valuable perspectives on the application of advanced diagnostics in high-acuity clinical environments. We look forward to seeing you there.

Challenged by rising costs, increasing complexity, and workforce shortages, healthcare systems are at a pivotal moment in development. Learn more from Angelo Rago and join the conversation. #businessreporter #healthcare #diagnosticstewardship #AIintegration #Luminex

A passion for science starts early — and thrives when given the right space to grow. At Diasorin, promoting scientific education in schools is not just a commitment. It’s part of who we are. Through Fondazione Diasorin, we support young talents and foster a hands-on, future-oriented approach to science learning. Congratulations to Liceo Scientifico Nino Cortese in Maddaloni (CE), winner of the 9th Mad For Science Challenge edition, and to all finalist schools: your passion is the best example of what scientific citizenship can look like. With over €1.5 million invested and more than 600 Italian schools involved, Fondazione Diasorin is a true expression of our social responsibility — and of our belief that investing in science education means investing in the future. #Diasorin  #FondazioneDiasorin #MadForScience  #STEMeducation  #SocialResponsibility  #ScienceForFuture  #ScientificCitizenship  #Innovation  #School

When choosing the appropriate test during respiratory season, it is crucial to consider your patient’s demographics, as various factors can affect the need for targeted testing or flexible panel approaches when matching the right test with the right patient at the right time. Download our Respiratory eBook and learn how patient demographics play an important role when choosing the right patient test.   https://hubs.li/Q03nwNqG0 #DiagnosticStewardship #RespiratoryHealth #Flexibletesting

We are pleased to announce that Dr. Kenneth Gavina’s Labroots webinar, “Not your average “tick talk” – An overview of tick-borne diseases and the diagnostic landscape,” is available online.  As the global incidence of tick-borne diseases continue to rise, understanding their epidemiology, clinical presentation, and diagnostic challenges has become increasingly important. Kenneth Gavina, PhD, D(ABMM), SM(ASCP)CM Medical Director, Clinical Microbiology and Serology Eskenazi Health Assistant Professor of Clinical Pathology and Laboratory Medicine Indiana University School of Medicine Watch this exciting presentation, which provides insights for those involved in public health, diagnostics, or clinical care. C.E. credits will be offered. https://hubs.li/Q03nn9TT0 #TickBornediseases #LabrootsWebinar #InfectiousDiseases #PublicHealth #ScienceWebinar

This past year, COVID-19 developed 2 distinct peaks—one in the summer, spanning from June to October, and the second in December coinciding with the flu season. This new seasonal pattern has motivated some labs to adjust their approach to respiratory testing, excluding targets like flu A, flu B, and RSV during the summer months in order to reduce cost and promote diagnostic stewardship. Download the new Diasorin Respiratory eBook to learn why seasonality should be considered when choosing the right test for the right patient at the right time. https://hubs.li/Q03kk81J0 #COVID19 #DiagnosticStewardship #RespiratoryHealth #Flexibletesting #eBook

Did you know that the CDC has classified Candida auris (C. auris) as an urgent microbial resistance threat, noting the alarming rate at which it has spread in healthcare facilities? Rapid identification of colonized patients can contribute to the achievement of better patient outcomes. Check out our blog, to learn more about this severe threat to public health. Learn more: https://hubs.li/Q03nx6bf0 #C.auris #Diasorin #MicrobialResistance #outbreak

This past year, COVID-19 developed 2 distinct peaks—one in the summer, spanning from June to October, and the second in December coinciding with the flu season. This new seasonal pattern has motivated some labs to adjust their approach to respiratory testing, excluding targets like flu A, flu B, and RSV during the summer months in order to reduce cost and promote diagnostic stewardship. Download the new Diasorin Respiratory eBook to learn why seasonality should be considered when choosing the right test for the right patient at the right time. https://hubs.li/Q03nmblh0 #COVID19 #DiagnosticStewardship #RespiratoryHealth #Flexibletesting #eBook

Join us at CAEP-ICEM When: May 23 - 28, 2025 Where: Palais des congrès de Montréal in Montreal, Quebec, Canada The International Conference on Emergency Medicine (ICEM) brings together professionals and experts from around the world to discuss the latest advancements and best practices in emergency medical care. Join us for six days of insightful sessions, interactive workshops, and networking opportunities. Learn more: https://www.icem2025.com/ We look forward to seeing you at Booth #123, where you can learn more about our LIAISON® MeMed BV® detection assay, which accurately distinguishes between bacterial and viral infections. #CAEP #ICEM #Microbiology #InfectiousDiseases #SpecialtyTesting

On World IBD Day, we stand with the 10 million people worldwide living with Inflammatory Bowel Disease. Early and precise diagnosis is essential in helping patients manage chronic conditions like Crohn’s disease and ulcerative colitis, improving quality of life and long-term outcomes. Today, we raise awareness and reaffirm our commitment to advancing diagnostics that make a real difference in patient care. #WorldIBDDay2025 #InflammatoryBowelDisease #IBD #CrohnsDisease #UlcerativeColitis #Diagnostics